DYRK1A inhibitors for disease therapy: Current status and perspectives
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference136 articles.
1. DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles;Aranda;Faseb. J.,2011
2. Master regulators in neurodegenerative pathways;Demuro;Int. J. Mol. Sci.,2021
3. Construction of miRNA-target networks using microRNA profiles of CVB3-infected HeLa cells;Yao;Sci. Rep.,2019
4. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation;Soppa;Cell Cycle,2014
5. MNB/DYRK1A as a multiple regulator of neuronal development;Tejedor;FEBS J.,2011
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects;Journal of Medicinal Chemistry;2024-09-10
2. Development and therapeutic perspectives of CXCR4 antagonists for disease therapy;European Journal of Medicinal Chemistry;2024-09
3. Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions;Frontiers in Molecular Neuroscience;2024-07-24
4. Beneficial Effects of Manilkara zapota-Derived Bioactive Compounds in the Epigenetic Program of Neurodevelopment;Nutrients;2024-07-11
5. ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease;Ageing Research Reviews;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3